Evidence map›Paper›PMID 31150022›Full record

ArticleNature reviews. Clinical oncology2019

Reply to 'Assembling the brain trust: the multidisciplinary imperative in neuro-oncology'.

Kenneth Aldape, Kevin M Brindle, Louis Chesler, Rajesh Chopra, Amar Gajjar, Mark R Gilbert, Nicholas Gottardo, David H Gutmann, Darren Hargrave, Eric C Holland and 16 more

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Nature reviews. Clinical oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors.

Kenneth AldapeDepartment of Pathology, University Health Network, Toronto, Ontario, Canada.
Kevin M BrindleCRUK Cambridge Institute, Li Ka Shing Centre, Cambridge, UK.
Louis CheslerThe Institute of Cancer Research, London, UK.
Rajesh ChopraThe Institute of Cancer Research, London, UK.
Amar GajjarDepartment of Oncology, St Jude Children's Research Hospital, Memphis, TN, USA.
Mark R GilbertCenter for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Nicholas GottardoTelethon Kids Institute, Subiaco, Western Australia, Australia.
David H GutmannDepartment of Neurology, Washington University School of Medicine, St. Louis, MO, USA.
Darren HargraveGreat Ormond Street Hospital for Children, Great Ormond Street, London, UK.
Eric C HollandHuman Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
David T W JonesPediatric Glioma Research Group, Hopp Children's Cancer Center at the NCT Heidelberg, Heidelberg, Germany.
Johanna A JoyceLudwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.
Pamela KearnsCancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham, UK.
Mark W KieranDana-Farber Boston Children's Cancer and Blood Disorder's Center and Harvard Medical School, Boston, MA, USA.
Ingo K MellinghoffHuman Oncology and Pathogenesis Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Melinda MerchantOncology, AstraZeneca IMED Biotech Unit, Boston, MA, USA.
Stefan M PfisterDivision of Pediatric Oncology, Hopp Children's Cancer Center at the NCT Heidelberg, Heidelberg, Germany.
Steven M PollardCancer Research UK Edinburgh Centre and Medical Research Council Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK.
Vijay RamaswamyDepartment of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0002-6557-895X
Jeremy N RichDivision of Regenerative Medicine, Department of Medicine, University of California, San Diego, San Diego, CA, USA.
Giles W RobinsonDepartment of Oncology, St Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0001-7441-9486
David H RowitchDepartment of Pediatrics, University of Cambridge and Wellcome Trust-MRC Stem Cell Institute, Cambridge, UK.
John H SampsonThe Preston Robert Tisch Brain Tumour Center, Duke Cancer Center, Durham, NC, USA.
Michael D TaylorThe Arthur and Sonia Labatt Brain Tumour Research Centre, and Division of Neurosurgery, The Hospital for Sick Children, Toronto, Ontario, Canada.
Paul WorkmanThe Institute of Cancer Research, London, UK.
Richard J GilbertsonCRUK Cambridge Institute, Li Ka Shing Centre, Cambridge, UK. richard.gilbertson@cruk.cam.ac.uk.ORCID http://orcid.org/0000-0001-7539-9472

Funding

The DNA Damage Response and Tumorigenesis in the BrainP01CA096832 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI BAKER, SUZANNE J. · 2003 to 2025
$38.0M
Cancer Research UK 16465Cancer Research UK 22492Cancer Research UK 22897Cancer Research UK 26398Cancer Research UK 28028Cancer Research UK 28289Cancer Research UK 28667NCI NIH HHS P01 CA096832
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Brain NeoplasmsBrainHumansMedical Oncology

Identifiers

PMID31150022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.